GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹419 Cr | ₹1,066 Cr | ₹921 Cr | ₹1,218 Cr | ₹1,091 Cr |
What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?
Year | Capital Work in Progress |
---|---|
Mar2024 | ₹419 Cr |
Mar2023 | ₹1,066 Cr |
Mar2022 | ₹921 Cr |
Mar2021 | ₹1,218 Cr |
Mar2020 | ₹1,091 Cr |
How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2024 | ₹419 Cr | -60.66 | |
Mar2023 | ₹1,066 Cr | 15.71 | |
Mar2022 | ₹921 Cr | -24.36 | |
Mar2021 | ₹1,218 Cr | 11.66 | |
Mar2020 | ₹1,091 Cr | - |
Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹58,050.0 Cr | 1.6% | -7.3% | 39.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹389,172.0 Cr | 1.8% | -3.6% | -7.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,248.0 Cr | -2.8% | -12.1% | 24% | Stock Analytics | |
CIPLA | ₹122,835.0 Cr | 2.3% | 2.4% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 2.9% | 6.5% | 8.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,869.0 Cr | 2% | -2.4% | -13.1% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 1.6% |
-7.3% |
39.2% |
SENSEX | -0.6% |
-2.8% |
1.7% |
You may also like the below Video Courses